Aspire Biopharma Holdings (ASBP) EBIT Margin (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly EBIT Margin came in at 5805.98% in Q1 2026, up 86.62% on a QoQ basis from 43403.52% in Q4 2025.
Aspire Biopharma Holdings (ASBP) EBIT Margin (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of EBIT Margin data on file, last reported at 5805.98% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | -5,805.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,805.98% |
| Dec 31, 2025 | -43,403.52% |
| Sep 30, 2025 | -59,015.82% |